Business
Peak Pharma Updates Market Positioning and Education of CBD Products
Peak Pharma Updates Market Positioning and Education of CBD Products.
About this update from Retrieve Medical Holdings Inc
[{"type":"text","content":"\n \n \n Peak Pharma Updates Market Positioning and Education of CBD Products\n \n \nPeak Pharma Updates Market Positioning and Education of CBD Products\n\nCompany Streamlines Product Mix and Targets Consumer Awareness of Hemp vs. Pot\n\n \n DENVER, CO--(Marketwired - Jun 30, 2015) - Peak Pharmaceuticals, Inc. (OTCQB: PKPH) (\"Peak Pharma\" or the \"Company\"), a leading innovator of non-prescription hemp based cannabinoid products, wishes to advise that plans for 2015 summer and fall marketing efforts are underway with a number of initiatives aimed at increasing revenues and growing consumer interest and confidence in its hemp based products.\n As part of the Company's overall growth strategy, an internal program is underway which aims to streamline the company's supply chain, including its different manufacturing processes, and to boost channel specific marketing efforts. The recently announced plan to introduce Canna-Pet® Advanced120, a new 120mg product designed for medium to large sized dogs, is another component of the efforts to boost the Company's product offering while delivering an enhanced, second generation Canna-Pet® product that incorporates customer feedback received over the past year. \n This consolidation of product lines will reduce manufacturing costs and minimize inventory investment while benefitting from economies of scale by using an outsourced, certified supplement manufacturing facility with a larger production capacity than the current Canna-Pet capability. As part of the new product development, the Company is well underway with package design updates better suited to the growing retail environment.\n In related news, the Company is excited by the continued growth in numbers of retailers and veterinarians who now stock our products on their shelves. As a result, management aims to invest in programs designed to reach and assist an even larger number of these very important market influencers within the next few months.\n Company CEO Dr. Soren Mogelsvang notes, \"Canna-Pet® continues to grow and prosper as we continue to refine and optimize our product portfolio to keep expanding our consumer base. Given that our product lineup is based on hemp, and as such, is virtually devoid of THC, we have been working to determine how this important differentiation from 'marijuana' or 'pot' product...